Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01216410 · ClinicalTrials.gov registry record · NA
Prevention of Intraoperative Nausea and Vomiting During Cesarean Section
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 306
- Enrollment target
NCT01216410 is a NA study that has completed, run by Duke University. The registered enrollment target is 306 participants.
The verdict
NCT01216410, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 306 participants
- Enrollment target
Study Summary
The study investigates the incidence of intraoperative nausea and vomiting under spinal anesthesia using a phenylephrine infusion with and without prophylactic antiemetics.
Interventions
- DRUG Metoclopramide
- DRUG Phenylephrine infusion
- DRUG Combination Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01216410
The ClinicalTrials.gov registry entry for NCT01216410 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Metoclopramide is the first listed.
NCT01216410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01216410 about?
NCT01216410 is a clinical study titled "Prevention of Intraoperative Nausea and Vomiting During Cesarean Section". The study investigates the incidence of intraoperative nausea and vomiting under spinal anesthesia using a phenylephrine infusion with and without prophylactic antiemetics.
What is the current status of trial NCT01216410?
This trial is currently completed. It is a NA study. The enrollment target is 306 participants. The study started on 2008-12. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01216410?
The interventions under investigation include: Metoclopramide (DRUG), Phenylephrine infusion (DRUG), Combination Group (DRUG).
Who is sponsoring clinical trial NCT01216410?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.